A newly identified trigger of brain inflammation could offer a fresh target for slowing Alzheimer's progression.
The brain has its own built-in immune system that identifies threats and responds to them. In Alzheimer's disease, growing evidence shows that this system becomes persistently overactive. The result is chronic inflammation that damages the connections between brain cells.
In a preclinical study using human Alzheimer's brain cells, scientists at Scripps Research have identified a molecular trigger behind this process. The finding points to a potential drug target that could help control harmful inflammation.
A Molecular Switch Behind Inflammation
The study, published in Cell Chemical Biology, focuses on a protein called STING. Under normal conditions, STING acts as part of the immune system's early warning network. In Alzheimer's brains, however, researchers found that STING undergoes a chemical change called S-nitrosylation (or SNO, a reaction involving sulfur, oxygen and nitrogen). This modification drives the protein into an overactive state. When scientists blocked this change in a mouse model, brain inflammation was reduced.
"This is a new and important therapeutic target for Alzheimer's disease," says senior author Stuart Lipton, the Step Family Foundation Endowed Chair at Scripps Research and a clinical neurologist. "It's exciting to see that blocking this switch in mice reduces inflammation and protects the very brain cell connections that are lost in Alzheimer's, especially because we found the same pathway to be activated in human Alzheimer's brain samples and in human stem cell-derived models."
More than 30 years ago, Lipton, who also co-directs the Neurodegeneration New Medicines Center at Scripps Research, first described S-nitrosylation. In this process, a molecule related to nitric oxide (NO) attaches to a cysteine amino acid in proteins, forming "SNO" and altering how the protein behaves.
His lab later showed that SNO can be triggered by aging, inflammation, and environmental exposures such as air pollution and wildfire smoke. These changes can disrupt many proteins throughout the body. This widespread effect, referred to as a "SNO-STORM," has been linked to diseases including cancer, Parkinson's disease, and Alzheimer's.
Pinpointing STING's Weak Spot
In the new study, researchers took a closer look at STING, which had already been associated with Alzheimer's-related inflammation. Lipton's team, led by postdoctoral researcher Lauren Carnevale, worked with Professor John Yates III, a mass spectrometry expert at Scripps Research and holder of the John Lytton Young Endowed Chair.
They identified the exact location where S-nitrosylation occurs on STING, focusing on a single amino acid known as cysteine 148. When this site is modified, STING forms clusters and sets off inflammatory signaling.
Elevated levels of this altered form, called SNO-STING, were detected in postmortem brain tissue from Alzheimer's patients, in lab-grown human brain immune cells exposed to Alzheimer's proteins, and in mice with the disease.
Further experiments revealed that hallmark Alzheimer's protein clumps, including amyloid-beta and alpha-synuclein, can directly trigger S-nitrosylation of STING. This suggests a feedback loop. Protein buildup, along with aging and environmental stress, may spark inflammation that produces nitric oxide. That, in turn, modifies STING and amplifies inflammation even further.
Protecting Brain Connections
To test this mechanism, the team created a version of STING that lacks cysteine 148, preventing the S-nitrosylation step. When introduced into a mouse model of Alzheimer's, this modified protein significantly reduced inflammation in brain immune cells.
Importantly, it also preserved synapses, the connections between nerve cells that are essential for memory and thinking. Loss of synapses is closely linked to cognitive decline in dementia, so protecting them is a key goal in Alzheimer's research.
"What makes this target particularly promising is that we can quiet the pathological overactivation of STING without shutting down the normal immune response," says Lipton. "You still need STING to protect yourself from infections, and when we target cysteine 148, we're not blocking the entire molecule; we're just preventing STING from becoming overactivated."
Lipton's team is now developing small molecules designed to block cysteine 148, with plans to test them in future preclinical studies.
Reference: "Redox regulation of neuroinflammatory pathways contributes to damage in Alzheimer's disease brain" by Lauren N. Carnevale, Piu Banerjee, Xu Zhang, Jazmin Navarro, Charlene K Raspur, Parth Patel, Tomohiro Nakamura, Emily Schahrer, Henry Scott, Nhi Lang, Jolene K. Diedrich, Amanda J. Roberts, John R. Yates and Stuart A. Lipton, 23 April 2026, Cell Chemical Biology.
DOI: 10.1016/j.chembiol.2026.03.017
This work was supported in part by the National Institutes of Health (R35 AG071734, U01 AG088679, RF1 AG057409, R01 AG078756, R01 AG056259, R01 DA048882, DP1 DA041722 and R01 AG077046), and the U.S. Department of Defense/U.S. Department of the Army (AR230101).
News – Curated by Amanda Scott, Alias Group Creative
Follow her on Bluesky
Why Most Animal Viruses Never Become Human Pandemics
From receptor mismatch to risky human-animal interfaces, this article explains why spillover is common but true pandemic emergence remains rare. Introduction Humans are constantly exposed to animal viruses through farming, wildlife contact, and the [...]
Stem cell organoids repair heart microvessels in coronary artery disease models
A Stanford University team has shown that vascular organoids derived from human stem cells can repair the heart’s microvessel network in pigs with ischaemic heart disease – a proof-of-concept advancement that could open new therapeutic [...]
Goodbye GP waiting rooms, hello prevention at home
Prevention is suddenly everywhere in NHS reform. The recent £340m community pharmacy deal is moving more services onto the high street. Community Diagnostic Centres are being expanded, and the Neighbourhood Health Framework sets out [...]
Ebola control is weakened by mistrust and cultural insensitivity
Effective response depends on cooperation with communities and frontline workers, writes Zaeem ul Haq The current Bundibugyo Ebola outbreak in the Democratic Republic of the Congo (DRC) and Uganda is exposing dangerous gaps in [...]
Building the Brain Requires Millions of Dangerous DNA Breaks
Scientists discovered that building a healthy brain involves an unexpected step: young neurons routinely break and rapidly repair their own DNA. As the brain develops, newly formed nerve cells must travel through tightly packed tissue [...]
One Tiny Change May Explain How Viruses Jump From Bats to Humans
Scientists found that one tiny genetic change may determine whether a bat virus stays in bats or becomes a human threat. Most infectious disease outbreaks begin when a virus or other pathogen crosses from animals into [...]
Scientists Discover 250+ Genes That Could Lead to New Ways To Prevent Melanoma
The world’s largest study of mole genetics identified hundreds of genes tied to melanoma risk, uncovering potential new drug targets and paving the way for more accurate melanoma screening and prevention. Researchers at QIMR [...]
Breakthrough Diabetes Treatment Reprograms the Immune System
An engineered stem cell therapy reversed new-onset Type 1 diabetes in mice by shifting the immune system away from attacking insulin-producing cells. For more than a century, people with Type 1 diabetes have relied [...]
Taking the world’s temperature: WHO chief spotlights global health emergencies
Taking the world’s temperature on pressing health matters, WHO Director-General Tedros Adhanom Ghebreyesus provided the latest on current global challenges - and successes when it comes to international cooperation. “The outbreaks of hantavirus, Ebola and Marburg all show [...]
Scientists Create Tiny “Mini Livers” That Could One Day Replace Liver Transplants
Engineered tissue grafts could help perform key liver functions and benefit thousands of people living with liver failure. The liver is one of the body’s hardest-working organs, carrying out hundreds of vital jobs, from [...]
NanoMedical Brain/Cloud Interface – Explorations and Implications. A new book from Frank Boehm
New book from Frank Boehm, NanoappsMedical Inc Founder: This book explores the future hypothetical possibility that the cerebral cortex of the human brain might be seamlessly, safely, and securely connected with the Cloud via [...]
Scientists Discover Surprising Way To Help the Brain Recover After Stroke
A new study suggests that strengthening the body’s natural circadian rhythms may help the brain recover after stroke, even when treatment begins days after the injury. Every year, millions of people survive a stroke, [...]
Our books now available worldwide!
Online Sellers other than Amazon, Routledge, and IOPP Indigo Global Health Care Equivalency in the Age of Nanotechnology, Nanomedicine and Artifcial Intelligence Global Health Care Equivalency In The Age Of Nanotechnology, Nanomedicine And Artificial [...]
Younger Generations Are Aging Faster – and It May Be Fueling a Surge in Cancer
Younger generations may be aging biologically faster than those before them, and that shift could help explain rising rates of cancer at younger ages. For decades, cancer was viewed largely as a disease of [...]
Using Cannabis Could Raise Your Stroke Risk by 37%, Massive Study Reveals
Large-scale evidence suggests cannabis, cocaine, and amphetamines may directly raise stroke risk, including in younger adults. As recreational drug use becomes increasingly common, researchers are uncovering evidence that its health consequences may extend far beyond [...]
Could Vitamin C Be the Secret to Keeping Your Brain Younger?
Lower vitamin C levels were linked to reduced brain volume and weaker neural connectivity in older adults, suggesting a potential connection between nutrition and brain health. Could a common vitamin help preserve the brain [...]
